Drug · DIN 02245744 · Veterinary
COMPONENT E-C IMPLANTS WITH TYLAN
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since June 12, 2019; first marketed May 18, 2016.
- Drug Identification Number (DIN)
- 02245744
- Company (DIN owner)
- Elanco Canada LimitedGuelph, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Implant
- Route
- Subcutaneous
- Class
- Veterinary
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| PROGESTERONE | 100 MG | |
| ESTRADIOL BENZOATE | 10 MG | |
| TYLOSIN TARTRATE | 29 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 7, 2019: NOC 22866Supplement to a New Drug Submission (SNDS) · Addition of a new manufacturing site ¿ Tylosin Tartrate
- February 14, 2018: NOC 20479New Drug Submission (NDS) · Merger - buyout
- January 8, 2018: NOC 20258Supplement to a New Drug Submission (SNDS) · Change to prescription status. labelling udpdates
- February 18, 2013: NOC 14134New Drug Submission (NDS) · Transfer of DIN ownerhsip
- May 21, 2002: NOC 6096New Drug Submission (NDS)